Jainey P. James, Pramatha, Mariyam Jouhara, Zakiya Fathima C, Rupal Ria D’Souza
Jainey P. James*, Pramatha, Mariyam Jouhara, Zakiya Fathima C, Rupal Ria D’Souza
Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences, NGSMIPS, Department of Pharmaceutical Chemistry, Paneer, Deralakatte, Mangalore - 575 018, Karnataka, India.
Volume - 16,
Issue - 5,
Year - 2023
Green synthesis of chalcones is a new alternative to traditional methods, which is eco-friendly and require no solvents. The chalcones exert their anticancer action by the different mechanisms by acting through various targets. The study aimed to synthesise chalcones by green chemistry approach using grinding technique and check their molecular interactions and pharmacokinetic profile by in silico studies. Their anti-breast cancer action was analysed by MTT assay against human breast cancer cells. ADMET and physicochemical properties emphasised the drug-likeness and bioavailability of the synthesised chalcones. All the twelve synthesised chalcones interacted well with the three cancer targets (3ERT, 4OAR and 4WKQ). Among them, the top chalcones were PR2 and PR3, excellently interacting with the targets, which are following the in vitro studies. PR2 and PR3 have obtained good cytotoxic action against human breast cancer cells. Based on these results, it is concluded that the synthesised chalcones can be utilised as leads as anti-breast cancer agents, which can be verified by in vivo studies as future studies.
Cite this article:
Jainey P. James, Pramatha, Mariyam Jouhara, Zakiya Fathima C, Rupal Ria D’Souza. Green Synthesis, Multitargeted Molecular Docking and ADMET Studies of Chalcones Based Scaffold as Anti-Breast Cancer Agents. Research Journal of Pharmacy and Technology 2023; 16(5):2215-2. doi: 10.52711/0974-360X.2023.00364
Jainey P. James, Pramatha, Mariyam Jouhara, Zakiya Fathima C, Rupal Ria D’Souza. Green Synthesis, Multitargeted Molecular Docking and ADMET Studies of Chalcones Based Scaffold as Anti-Breast Cancer Agents. Research Journal of Pharmacy and Technology 2023; 16(5):2215-2. doi: 10.52711/0974-360X.2023.00364 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2023-16-5-23
1. Deeb O, Goodarzi M. In silico quantitative structure toxicity relationship of chemical compounds: some case studies. Current Drug Safety. 2012 Sep 1;7(4):289-97.
2. Colquitt RB, Colquhoun DA, Thiele RH. In silico modelling of physiologic systems. Best practice & research Clinical Anaesthesiology. 2011 Dec 1;25(4):499-510.
3. Tamboli FA, More HN. Inhibitory Effects of Successive Solvant Extracts of Barleria gibsoni Dalz. on the Proliferation of MDA MB 4355 (Human Breast Cancer) and Hep G2 (Liver Cancer Cell line). Asian J. Pharm. Res. 2015 Dec 1;5(4):183-5.
4. Thomas R, Weihua Z. Rethink of EGFR in cancer with its kinase independent function on board. Frontiers in Oncology. 2019 Aug 23;9:800. https://doi.org/10.3389/fonc.2019.00800\
5. Moreno LM, Quiroga J, Abonia R, Lauria A, Martorana A, Insuasty H, Insuasty B. Synthesis, biological evaluation, and in silico studies of novel chalcone-and pyrazoline-based 1, 3, 5-triazines as potential anticancer agents. RSC Advances. 2020;10(56):34114-29.
6. Daniel AR, Hagan CR, Lange CA. Progesterone receptor action: defining a role in breast cancer. Expert Review of Endocrinology & Metabolism. 2011 May 1;6(3):359-69. https://doi.org/10.1586/eem.11.25
7. Shntaif AH. Green synthesis of chalcones under microwave irradiation. International Journal of ChemTech Research. 2016;9(02):36-9.
8. Ahmad MR, Sastry VG, Bano N, Anwar S. Synthesis of novel chalcone derivatives by conventional and microwave irradiation methods and their pharmacological activities. Arabian Journal of Chemistry. 2016 Sep 1;9:S931-5.
9. Ritter M, Martins RM, Rosa SA, Malavolta JL, Lund RG, Flores AF, Pereira CM. Green synthesis of chalcones and microbiological evaluation. Journal of the Brazilian Chemical Society. 2015 Jun 1;26:1201-10.
10. DiGiacomo JW, Godet I, Trautmann-Rodriguez M, Gilkes DM. Extracellular Matrix–Bound FGF2 Mediates Estrogen Receptor Signaling and Therapeutic Response in Breast Cancer. Molecular Cancer Research. 2021 Jan 1;19(1):136-49.
11. Dawane BS, Shaikh BM, Khandare NT, Mandawad GG, Chobe SS, Konda SG. Synthesis of Some Novel Substituted Pyrazole Based Chalcones and Their In-Vitro Antimicrobial Activity. Asian Journal of Research in Chemistry. 2010;3(1):90-3.
12. Beena KP, Rajesh P, Nathiya S. Synthesis of Some Novel Substituted Isoxazoline Based Chalcones and Their In-Vitro Antimicrobial Activity. Asian Journal of Research in Chemistry. 2010;3(4):1080-2.
13. Hipparagi SM, Bhanushali MD, Patil SA, Desai NS. Synthesis and anti-infective studies of some novel pyrazoline derivatives. Asian Journal of Research in Chemistry. 2012 Oct 28;5(10):1251-4.
14. Elias DW, Beazely MA, Kandepu NM. Bioactivities of chalcones. Current Medicinal Chemistry. 1999;6(12):1125.
15. Mokle SS, Sayyed MA, Vibhute AY, Khansole SV, Nalwar YS, Vibhute YB. Synthesis of Some New Bioactive Chalcones and Flavones. Research Journal of Pharmacy and Technology. 2009;2(4):846-9.
16. Lunkad AS, Kothawade SN, Jadhav DV, Chaudhari PS, Bornare SP. Synthesis and Antimicrobial Activity of Some New Chalcones Containing Benzofuran and Benzofuran Schiff Bases. Research Journal of Pharmacy and Technology. 2015;8(3):276-9.
17. Kumar P, Kumar A, D'Souza S. Synthesis and Antimicrobial Evaluation of Different Substituted Phenylpropenone Pyrrolyl Chalcones. Research Journal of Pharmacy and Technology. 2017;10(5):1426-8.
18. Anto RJ, Sukumaran K, Kuttan G, Rao MN, Subbaraju V, Kuttan R. Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Letters. 1995 Oct 20;97(1):33-7.
19. Hans RH, Guantai EM, Lategan C, Smith PJ, Wan B, Franzblau SG, Gut J, Rosenthal PJ, Chibale K. Synthesis, antimalarial and antitubercular activity of acetylenic chalcones. Bioorganic & Medicinal Chemistry Letters. 2010 Feb 1;20(3):942-4.
20. Edwards ML, Stemerick DM, Sunkara PS. Chalcones: a new class of antimitotic agents. Journal of medicinal chemistry. 1990 Jul;33(7):1948-54.
21. Das M, Manna K. Chalcone scaffold in anticancer armamentarium: a molecular insight. Journal of Toxicology. 2016 Jan 3;2016.
22. Xiao J, Gao M, Diao Q, Gao F. Chalcone Derivatives and their Activities against Drug-resistant Cancers: An Overview. Current Topics in Medicinal Chemistry. 2021 Feb 1;21(5):348-62.
23. Hemalatha K, Girija K. Evaluation of drug candidature of some benzimidazole derivatives as biotin carboxylase inhibitors: molecular docking and insilico studies. Asian Journal of Research in Pharmaceutical Science. 2016;6(1):15-20.
24. Hemalatha K, Selvin J, Girija K. Synthesis, In silico Molecular Docking Study and Anti-bacterial Evaluation of some Novel 4-Anilino Quinazolines. Asian Journal of Pharmaceutical Research. 2018;8(3):125-32.
25. Sindhu TJ, Akhilesh KJ, Jose A, Binsiya KP, Thomas B, Wilson E. Antiviral screening of Clerodol derivatives as COV 2 main protease inhibitor in Novel Corona Virus Disease: In silico approaches. Asian Journal of Pharmacy and Technology. 2020;10(2):60-4.
26. Yadav P, Lal K, Kumar A, Guru SK, Jaglan S, Bhushan S. Green synthesis and anticancer potential of chalcone linked-1, 2, 3-triazoles. European Journal of Medicinal Chemistry. 2017 Jan 27;126:944-53.
27. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 1998 Dec 23;95(7):927-37.
28. Petit-Topin I, Fay M, Resche-Rigon M, Ulmann A, Gainer E, Rafestin-Oblin ME, Fagart J. Molecular determinants of the recognition of ulipristal acetate by oxo-steroid receptors. The Journal of Steroid Biochemistry and Molecular Biology. 2014 Oct 1;144:427-35.
29. PDB Database, https://www.rcsb.org/structure/4WKQ
30. Schrodinger. Schrodinger Release 2020–4: https://www.schrodinger.com
31. Schrodinger. Schrodinger Release. 2020–4: Glide; 2020. https://www.schrodinger.com/ Glide
32. Friesner RA, Murphy RB, Repasky MP, Frye LL. Greenwood JR, Halgren TA, et al. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein− ligand complexes. Journal of Medicinal Chemistry. 2006;49(21): pp.6177-6196. https://doi.org/10.1021/jm051256o
33. James JP, Kumar P, Kumar A, Bhat KI, Shastry CS. In Silico Anticancer Evaluation, Molecular Docking and Pharmacophore Modeling of Flavonoids against Various Cancer Targets. Letters in Drug Design & Discovery. 2020;17(12);1485-1501. https://doi.org/10.2174/1570180817999200730164222
34. Jainab NH, Raja MK. In silico molecular docking studies on the chemical constituents of clerodendrum phlomidis for its cytotoxic potential against breast cancer markers. Research Journal of Pharmacy and Technology. 2018;11(4):1612-8.
35. Schrödinger Release 2020-4: Prime, Schrödinger, LLC, New York, NY, 2020.
36. Schrödinger Release 2020-4: QikProp, Schrödinger, LLC, New York, NY, 2020.
37. Kodical DD, James JP, Deepthi K, Kumar P, Cyriac C, Gopika KV. ADMET, Molecular docking studies and binding energy calculations of Pyrimidine-2-Thiol Derivatives as Cox Inhibitors. Research Journal of Pharmacy and Technology. 2020;13(9):4200-4206. https://doi.org/10.5958/0974-360x.2020.00742.8
38. Francis D, Rita L. Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Method. 1986; 89: 271-277.
39. James JP. Aiswarya TC, Priya, S, Jyothi D, Dixit SR. Structure-based multitargeted molecular docking analysis of pyrazole-condensed heterocyclics against lung cancer. International Journal of Applied Pharmaceutics. 2021;13(6):157–169. https://doi.org/10.22159/ijap.2021v13i6.42